Slingshot Unveils a Novel Cell Therapy-Focused Portfolio to Streamline Development while Improving Manufacturing and Clinical Trial Capabilities
[ad_1]
EMERYVILLE, Calif.–(BUSINESS WIRE)–In response to strong customer demand, Slingshot Biosciences is introducing a groundbreaking portfolio of products that will transform the landscape of analytical precision in cell therapy. Its first products in this category are aimed at solving quality control challenges that plague current cell therapy development and manufacturing processes. In the evolving field of cell therapy, the development and delivery of potent and effective products are heavily d
[ad_2]
